These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 700519)
21. Structure-activity relationships in further series of amino-halogen substituted phenyl-aminoethanols. Engelhardt G Arzneimittelforschung; 1984; 34(11A):1625-32. PubMed ID: 6152155 [TBL] [Abstract][Full Text] [Related]
22. The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients. Marlin GE; Turner P Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):158-69. PubMed ID: 240780 [TBL] [Abstract][Full Text] [Related]
23. Oral clenbuterol and procaterol. A double-blind comparison of bronchodilator effects in children with chronic asthma. Boner AL; Sette L; Castellani C; Schiassi M J Asthma; 1987; 24(6):347-53. PubMed ID: 2965140 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic studies of mabuterol, a new selective beta 2-stimulant. II: Urinary metabolites of mabuterol in rats and their pharmacological effects. Horiba M; Murai T; Nomura K; Yuge T; Sanai K; Osada E Arzneimittelforschung; 1984; 34(11A):1668-79. PubMed ID: 6152160 [TBL] [Abstract][Full Text] [Related]
25. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). I. Action on respiratory function and acute toxicity. Rispat G; Burgi H; Cosnier D; Duchêne-Marullaz P; Streichenberger G Arzneimittelforschung; 1976 Apr; 26(4):523-30. PubMed ID: 8057 [TBL] [Abstract][Full Text] [Related]
26. Antitussive activity and other related pharmacological properties of d-3-methyl-N-methylmorphinan (AT-17). Kasé Y; Kito G; Miyata T; Uno T; Takahama K; Ida H Arzneimittelforschung; 1976; 26(3):353-60. PubMed ID: 989326 [TBL] [Abstract][Full Text] [Related]
27. Studies on tetrahydroisoquinolines (THI). VI. Effects of trimetoquinol on tracheal and some other smooth muscles. Kiyomoto A; Iwasawa Y; Harigaya S Arzneimittelforschung; 1970 Jan; 20(1):46-52. PubMed ID: 4392500 [No Abstract] [Full Text] [Related]
28. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties. Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834 [TBL] [Abstract][Full Text] [Related]
29. [The influence of serum theophylline concentration on the bronchodilating effect of salbutamol inhalation for bronchial asthma]. Tsukioka K; Nakamata M; Kondo A; Hashimoto T Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jul; 28(7):950-5. PubMed ID: 1977948 [TBL] [Abstract][Full Text] [Related]
30. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system]. Nakamura T; Miura Y; Aihara K; Satoh H; Goto K; Tsumagari T Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):79-92. PubMed ID: 6137441 [TBL] [Abstract][Full Text] [Related]
31. [Comparative study of clenbuterol and isoprenaline on cardiac contractility and tidal respiratory volume (author's transl)]. Orts A; Martí JL; Baltar I; Castejón JV; Esplugues J Arch Farmacol Toxicol; 1980 Apr; 6(1):67-74. PubMed ID: 7387205 [No Abstract] [Full Text] [Related]
32. [Histochemical experiments on the action of clenbuterol on tracheal mucosa (author's transl)]. Schätzle W; Federspil P Arzneimittelforschung; 1978; 28(7):1116-8. PubMed ID: 582698 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems. Hirohashi M; Takasuna K; Yamashita N; Tamura K Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573 [TBL] [Abstract][Full Text] [Related]
34. The bronchodilator and cardiac stimulant effects of Thll65a, salbutamol and isoproterenol. Giles RE; Williams JC; Finkel MP J Pharmacol Exp Ther; 1973 Sep; 186(3):472-81. PubMed ID: 4147005 [No Abstract] [Full Text] [Related]
35. Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Warrell DA; Robertson DG; Howes JN; Conolly ME; Paterson JW; Beilin LJ; Dollery CT Br Med J; 1970 Jan; 1(5688):65-70. PubMed ID: 5411446 [TBL] [Abstract][Full Text] [Related]
36. General pharmacology of the new antimuscarinic compound vamicamide. Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084 [TBL] [Abstract][Full Text] [Related]
37. [On the cardiac and hemodynamic side-effects of the beta 2-adrenergic broncholytic agent clenbuterol (Contraspasmin)]. Femmer K; Heer S Pharmazie; 1982 Aug; 37(8):584-6. PubMed ID: 7146067 [TBL] [Abstract][Full Text] [Related]
38. Effects of clenbuterol hydrochloride on certain respiratory and cardiovascular parameters in horses performing treadmill exercise. Rose RJ; Allen JR; Brock KA; Clark CR; Hodgson DR; Stewart JH Res Vet Sci; 1983 Nov; 35(3):301-5. PubMed ID: 6665313 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the action of BD 40 A and some other beta-adrenoceptor stimulants on the isolated trachea and atria of the guinea pig. Ida H Arzneimittelforschung; 1976; 26(5):839-42. PubMed ID: 9101 [TBL] [Abstract][Full Text] [Related]
40. Pharmacologic potency and selectivity of a new bronchodilator agent, 2,3-dihydro-7-methyl-9-phenyl-1H-pyrazolo [1,2-a] indazolium bromide (FKK) on canine tracheal preparations "in vivo" and "in vitro". Shiraki Y; Sakai K Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):150-63. PubMed ID: 6870387 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]